- Country: Ukraine
- Summary: Lipoic Acid Solution for Infusions, 30 Mg/Ml in 20 Ml; Lipoic Acid Film-Coated Tablets, 600 Mg Each; Arginine Glutamate, Tablets, 0.75 G Each; Amlodipine/Valsartan/Hydrochlorothiazide 5...
- UAT Ref No: 131168884
- Deadline: 03 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 268480
- Notice Type: Tender
- Document Ref. No.: UA-2025-11-28-015290-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lipoic acid solution for infusions, 30 mg/ml in 20 ml; Lipoic acid film-coated tablets, 600 mg each; Arginine glutamate, tablets, 0.75 g each; Amlodipine/valsartan/hydrochlorothiazide 5 mg/160 mg/12.5 mg tablets; Valsartan/hydrochlorothiazide tablets 160 mg/25 mg; Amlodipine 10 mg tablets; Furosemide, tablets, 40 mg each; Betamethasone suspension for injection, 7 mg/ml per 1 ml; Miramistin spray for the oral cavity, dose of the active ingredient: 0.1 mg/ml, ATC: D08AJ; Trazodone 150 mg tablets; Metronidazole 250 tablets/capsules; Tranexamic acid solution for injection, 50 mg/ml in 10 ml; Salbutamol, solution for inhalation, 2.5 mg/2.5 ml, 2.5 ml each Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Lipoic acid solution for infusions, 30 mg/ml 20 ml Thioctic acid, A16AX01, Solution for infusions, 30 mg/ml, 20, Ampoule, Vial; Lipoic acid film-coated tablets, 600 mg Thioctic acid, A16AX01, Film-coated tablets shell, 600 mg, Blister; Valsartan/hydrochlorothiazide tablets 160 mg/25 mg Classification according to ATC: C09DA03, Classification according to INN: Valsartan and diuretics, Release form: Film-coated tablets, Dose of active substance: 160 mg/25 mg; Classification according to ATX: D08AJ, Classification according to INN: Myramistin*, Release form: Spray for the oral cavity, Dose of the active substance: 0.1 mg/ml Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Lipoic acid solution for infusions, 30 mg/ml 20 ml Thioctic acid, A16AX01, Solution for infusions, 30 mg/ml, 20, Ampoule, Vial; Lipoic acid film-coated tablets, 600 mg Thioctic acid, A16AX01, Tablets, coated film shell, 600 mg, Blister; Valsartan/hydrochlorothiazide tablets 160 mg/25 mg Classification according to ATC: C09DA03, Classification according to INN: Valsartan and diuretics, Release form: Film-coated tablets, Dose of active s...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLipoic Acid Solution for Infusions, 30 Mg/Ml in 20 Ml; Lipoic Acid Film-Coated Tablets, 600 Mg Each; Arginine Glutamate, Tablets, 0.75 G Each; Amlodipine/Valsartan/Hydrochlorothiazide 5... - Ukraine Tender
The MILITARY UNIT A 1446, a Government sector organization in Ukraine, has announced a new tender for Lipoic Acid Solution for Infusions, 30 Mg/Ml in 20 Ml; Lipoic Acid Film-Coated Tablets, 600 Mg Each; Arginine Glutamate, Tablets, 0.75 G Each; Amlodipine/Valsartan/Hydrochlorothiazide 5.... This tender is published on UkraineTenders under UAT Ref No: 131168884 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-03.
The estimated tender value is UAH 268480, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
